Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:immunodeficiency secondary to neoplasm'
(id=6986906 ; fe=en:immunodeficiency secondary to neoplasm ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=2917 creation date=2017-06-25 touchdate=2025-12-19 15:34:13.000)
≈ 51 relations sortantes

  1. en:immunodeficiency secondary to neoplasm -- r_associated #0: 159 / 1 -> médecine
    n1=en:immunodeficiency secondary to neoplasm | n2=médecine | rel=r_associated | relid=0 | w=159
  2. en:immunodeficiency secondary to neoplasm -- r_associated #0: 37 / 0.233 -> en:immunodeficiency secondary to oncology chemotherapy
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immunodeficiency secondary to oncology chemotherapy | rel=r_associated | relid=0 | w=37
  3. en:immunodeficiency secondary to neoplasm -- r_associated #0: 35 / 0.22 -> en:age-related immunodeficiency
    n1=en:immunodeficiency secondary to neoplasm | n2=en:age-related immunodeficiency | rel=r_associated | relid=0 | w=35
  4. en:immunodeficiency secondary to neoplasm -- r_associated #0: 35 / 0.22 -> en:immunodeficiency secondary to trauma
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immunodeficiency secondary to trauma | rel=r_associated | relid=0 | w=35
  5. en:immunodeficiency secondary to neoplasm -- r_associated #0: 34 / 0.214 -> en:immunodeficiency secondary to organ transplantation
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immunodeficiency secondary to organ transplantation | rel=r_associated | relid=0 | w=34
  6. en:immunodeficiency secondary to neoplasm -- r_associated #0: 34 / 0.214 -> en:immunodeficiency secondary to transplantation chemotherapy
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immunodeficiency secondary to transplantation chemotherapy | rel=r_associated | relid=0 | w=34
  7. en:immunodeficiency secondary to neoplasm -- r_associated #0: 32 / 0.201 -> en:acquired immunodeficiency syndrome
    n1=en:immunodeficiency secondary to neoplasm | n2=en:acquired immunodeficiency syndrome | rel=r_associated | relid=0 | w=32
  8. en:immunodeficiency secondary to neoplasm -- r_associated #0: 31 / 0.195 -> en:neoplastic syndrome
    n1=en:immunodeficiency secondary to neoplasm | n2=en:neoplastic syndrome | rel=r_associated | relid=0 | w=31
  9. en:immunodeficiency secondary to neoplasm -- r_associated #0: 30 / 0.189 -> en:immunodeficiency secondary to radiation therapy
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immunodeficiency secondary to radiation therapy | rel=r_associated | relid=0 | w=30
  10. en:immunodeficiency secondary to neoplasm -- r_associated #0: 30 / 0.189 -> en:secondary antibody deficiency
    n1=en:immunodeficiency secondary to neoplasm | n2=en:secondary antibody deficiency | rel=r_associated | relid=0 | w=30
  11. en:immunodeficiency secondary to neoplasm -- r_associated #0: 29 / 0.182 -> en:immunodeficiency following hereditary defective response to epstein-barr virus
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immunodeficiency following hereditary defective response to epstein-barr virus | rel=r_associated | relid=0 | w=29
  12. en:immunodeficiency secondary to neoplasm -- r_associated #0: 29 / 0.182 -> en:immunodeficiency secondary to chemotherapy
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immunodeficiency secondary to chemotherapy | rel=r_associated | relid=0 | w=29
  13. en:immunodeficiency secondary to neoplasm -- r_associated #0: 29 / 0.182 -> en:immunodeficiency secondary to measles
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immunodeficiency secondary to measles | rel=r_associated | relid=0 | w=29
  14. en:immunodeficiency secondary to neoplasm -- r_associated #0: 29 / 0.182 -> en:secondary immune deficiency disorder
    n1=en:immunodeficiency secondary to neoplasm | n2=en:secondary immune deficiency disorder | rel=r_associated | relid=0 | w=29
  15. en:immunodeficiency secondary to neoplasm -- r_associated #0: 28 / 0.176 -> déficit immunitaire secondaire à un cancer
    n1=en:immunodeficiency secondary to neoplasm | n2=déficit immunitaire secondaire à un cancer | rel=r_associated | relid=0 | w=28
  16. en:immunodeficiency secondary to neoplasm -- r_associated #0: 28 / 0.176 -> en:common variable immunodeficiency
    n1=en:immunodeficiency secondary to neoplasm | n2=en:common variable immunodeficiency | rel=r_associated | relid=0 | w=28
  17. en:immunodeficiency secondary to neoplasm -- r_associated #0: 28 / 0.176 -> en:drug-induced immunodeficiency
    n1=en:immunodeficiency secondary to neoplasm | n2=en:drug-induced immunodeficiency | rel=r_associated | relid=0 | w=28
  18. en:immunodeficiency secondary to neoplasm -- r_associated #0: 28 / 0.176 -> immunodéficience secondaire à un néoplasme
    n1=en:immunodeficiency secondary to neoplasm | n2=immunodéficience secondaire à un néoplasme | rel=r_associated | relid=0 | w=28
  19. en:immunodeficiency secondary to neoplasm -- r_associated #0: 27 / 0.17 -> en:immunodeficiency secondary to corticosteroid
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immunodeficiency secondary to corticosteroid | rel=r_associated | relid=0 | w=27
  20. en:immunodeficiency secondary to neoplasm -- r_associated #0: 26 / 0.164 -> en:immunodeficiency secondary to chemotherapy (excluding corticosteroids)
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immunodeficiency secondary to chemotherapy (excluding corticosteroids) | rel=r_associated | relid=0 | w=26
  21. en:immunodeficiency secondary to neoplasm -- r_associated #0: 26 / 0.164 -> néoplasme
    n1=en:immunodeficiency secondary to neoplasm | n2=néoplasme | rel=r_associated | relid=0 | w=26
  22. en:immunodeficiency secondary to neoplasm -- r_associated #0: 25 / 0.157 -> en:immunodeficiency
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immunodeficiency | rel=r_associated | relid=0 | w=25
  23. en:immunodeficiency secondary to neoplasm -- r_associated #0: 21 / 0.132 -> en:immune system finding
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immune system finding | rel=r_associated | relid=0 | w=21
  24. en:immunodeficiency secondary to neoplasm -- r_associated #0: 20 / 0.126 -> anti-sida
    n1=en:immunodeficiency secondary to neoplasm | n2=anti-sida | rel=r_associated | relid=0 | w=20
  25. en:immunodeficiency secondary to neoplasm -- r_associated #0: 20 / 0.126 -> antisida
    n1=en:immunodeficiency secondary to neoplasm | n2=antisida | rel=r_associated | relid=0 | w=20
  26. en:immunodeficiency secondary to neoplasm -- r_associated #0: 20 / 0.126 -> en:AIDS
    n1=en:immunodeficiency secondary to neoplasm | n2=en:AIDS | rel=r_associated | relid=0 | w=20
  27. en:immunodeficiency secondary to neoplasm -- r_associated #0: 20 / 0.126 -> en:AIDS awareness
    n1=en:immunodeficiency secondary to neoplasm | n2=en:AIDS awareness | rel=r_associated | relid=0 | w=20
  28. en:immunodeficiency secondary to neoplasm -- r_associated #0: 20 / 0.126 -> en:disease aids
    n1=en:immunodeficiency secondary to neoplasm | n2=en:disease aids | rel=r_associated | relid=0 | w=20
  29. en:immunodeficiency secondary to neoplasm -- r_associated #0: 20 / 0.126 -> en:immune deficiency syndrome
    n1=en:immunodeficiency secondary to neoplasm | n2=en:immune deficiency syndrome | rel=r_associated | relid=0 | w=20
  30. en:immunodeficiency secondary to neoplasm -- r_associated #0: 20 / 0.126 -> présentation sacro-iliaque droite antérieure
    n1=en:immunodeficiency secondary to neoplasm | n2=présentation sacro-iliaque droite antérieure | rel=r_associated | relid=0 | w=20
  31. en:immunodeficiency secondary to neoplasm -- r_associated #0: 20 / 0.126 -> S.I.D.A.
    n1=en:immunodeficiency secondary to neoplasm | n2=S.I.D.A. | rel=r_associated | relid=0 | w=20
  32. en:immunodeficiency secondary to neoplasm -- r_associated #0: 20 / 0.126 -> SIDA
    n1=en:immunodeficiency secondary to neoplasm | n2=SIDA | rel=r_associated | relid=0 | w=20
  33. en:immunodeficiency secondary to neoplasm -- r_associated #0: 20 / 0.126 -> syndrome d'immunodéficience acquise
    n1=en:immunodeficiency secondary to neoplasm | n2=syndrome d'immunodéficience acquise | rel=r_associated | relid=0 | w=20
  34. en:immunodeficiency secondary to neoplasm -- r_associated #0: 20 / 0.126 -> syndrome de l'immunodéficience acquise
    n1=en:immunodeficiency secondary to neoplasm | n2=syndrome de l'immunodéficience acquise | rel=r_associated | relid=0 | w=20
  35. en:immunodeficiency secondary to neoplasm -- r_associated #0: 15 / 0.094 -> carcinologie
    (oncologie)
    n1=en:immunodeficiency secondary to neoplasm | n2=carcinologie
    (oncologie)
    | rel=r_associated | relid=0 | w=15
  36. en:immunodeficiency secondary to neoplasm -- r_associated #0: 15 / 0.094 -> en:oncology
    n1=en:immunodeficiency secondary to neoplasm | n2=en:oncology | rel=r_associated | relid=0 | w=15
  37. en:immunodeficiency secondary to neoplasm -- r_associated #0: 15 / 0.094 -> en:specialized branches of medicine
    n1=en:immunodeficiency secondary to neoplasm | n2=en:specialized branches of medicine | rel=r_associated | relid=0 | w=15
  38. en:immunodeficiency secondary to neoplasm -- r_associated #0: 15 / 0.094 -> Spécialités médicales
    n1=en:immunodeficiency secondary to neoplasm | n2=Spécialités médicales | rel=r_associated | relid=0 | w=15
  39. en:immunodeficiency secondary to neoplasm -- r_associated #0: 15 / 0.094 -> spécialités médicales
    n1=en:immunodeficiency secondary to neoplasm | n2=spécialités médicales | rel=r_associated | relid=0 | w=15
  40. en:immunodeficiency secondary to neoplasm -- r_associated #0: 15 / 0.094 -> tumeurs
    n1=en:immunodeficiency secondary to neoplasm | n2=tumeurs | rel=r_associated | relid=0 | w=15
  41. en:immunodeficiency secondary to neoplasm -- r_associated #0: 5 / 0.031 -> cancer
    n1=en:immunodeficiency secondary to neoplasm | n2=cancer | rel=r_associated | relid=0 | w=5
  42. en:immunodeficiency secondary to neoplasm -- r_associated #0: 5 / 0.031 -> cancérologie
    n1=en:immunodeficiency secondary to neoplasm | n2=cancérologie | rel=r_associated | relid=0 | w=5
  43. en:immunodeficiency secondary to neoplasm -- r_associated #0: 5 / 0.031 -> carcinologie
    n1=en:immunodeficiency secondary to neoplasm | n2=carcinologie | rel=r_associated | relid=0 | w=5
  44. en:immunodeficiency secondary to neoplasm -- r_associated #0: 5 / 0.031 -> en:cancer research
    n1=en:immunodeficiency secondary to neoplasm | n2=en:cancer research | rel=r_associated | relid=0 | w=5
  45. en:immunodeficiency secondary to neoplasm -- r_associated #0: 5 / 0.031 -> en:cancrology
    n1=en:immunodeficiency secondary to neoplasm | n2=en:cancrology | rel=r_associated | relid=0 | w=5
  46. en:immunodeficiency secondary to neoplasm -- r_associated #0: 5 / 0.031 -> en:carcinology
    n1=en:immunodeficiency secondary to neoplasm | n2=en:carcinology | rel=r_associated | relid=0 | w=5
  47. en:immunodeficiency secondary to neoplasm -- r_associated #0: 5 / 0.031 -> maladies
    n1=en:immunodeficiency secondary to neoplasm | n2=maladies | rel=r_associated | relid=0 | w=5
  48. en:immunodeficiency secondary to neoplasm -- r_associated #0: 5 / 0.031 -> Médecine
    n1=en:immunodeficiency secondary to neoplasm | n2=Médecine | rel=r_associated | relid=0 | w=5
  49. en:immunodeficiency secondary to neoplasm -- r_associated #0: 5 / 0.031 -> médecine spécialisée
    n1=en:immunodeficiency secondary to neoplasm | n2=médecine spécialisée | rel=r_associated | relid=0 | w=5
  50. en:immunodeficiency secondary to neoplasm -- r_associated #0: 5 / 0.031 -> oncologie
    n1=en:immunodeficiency secondary to neoplasm | n2=oncologie | rel=r_associated | relid=0 | w=5
  51. en:immunodeficiency secondary to neoplasm -- r_associated #0: 2 / 0.013 -> en:pathologic function
    n1=en:immunodeficiency secondary to neoplasm | n2=en:pathologic function | rel=r_associated | relid=0 | w=2
≈ 41 relations entrantes

  1. médecine --- r_associated #0: 130 --> en:immunodeficiency secondary to neoplasm
    n1=médecine | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=130
  2. syndrome de l'immunodéficience acquise --- r_associated #0: 90 --> en:immunodeficiency secondary to neoplasm
    n1=syndrome de l'immunodéficience acquise | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=90
  3. en:acquired immunodeficiency syndrome --- r_associated #0: 89 --> en:immunodeficiency secondary to neoplasm
    n1=en:acquired immunodeficiency syndrome | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=89
  4. syndrome d'immunodéficience acquise --- r_associated #0: 85 --> en:immunodeficiency secondary to neoplasm
    n1=syndrome d'immunodéficience acquise | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=85
  5. SIDA --- r_associated #0: 75 --> en:immunodeficiency secondary to neoplasm
    n1=SIDA | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=75
  6. anti-sida --- r_associated #0: 68 --> en:immunodeficiency secondary to neoplasm
    n1=anti-sida | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=68
  7. en:AIDS --- r_associated #0: 65 --> en:immunodeficiency secondary to neoplasm
    n1=en:AIDS | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=65
  8. antisida --- r_associated #0: 64 --> en:immunodeficiency secondary to neoplasm
    n1=antisida | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=64
  9. en:immune deficiency syndrome --- r_associated #0: 60 --> en:immunodeficiency secondary to neoplasm
    n1=en:immune deficiency syndrome | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=60
  10. en:disease aids --- r_associated #0: 55 --> en:immunodeficiency secondary to neoplasm
    n1=en:disease aids | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=55
  11. en:AIDS awareness --- r_associated #0: 49 --> en:immunodeficiency secondary to neoplasm
    n1=en:AIDS awareness | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=49
  12. S.I.D.A. --- r_associated #0: 42 --> en:immunodeficiency secondary to neoplasm
    n1=S.I.D.A. | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=42
  13. en:immunodeficiency secondary to measles --- r_associated #0: 42 --> en:immunodeficiency secondary to neoplasm
    n1=en:immunodeficiency secondary to measles | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=42
  14. en:secondary antibody deficiency --- r_associated #0: 39 --> en:immunodeficiency secondary to neoplasm
    n1=en:secondary antibody deficiency | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=39
  15. en:immunodeficiency secondary to trauma --- r_associated #0: 34 --> en:immunodeficiency secondary to neoplasm
    n1=en:immunodeficiency secondary to trauma | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=34
  16. en:drug-induced immunodeficiency --- r_associated #0: 32 --> en:immunodeficiency secondary to neoplasm
    n1=en:drug-induced immunodeficiency | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=32
  17. en:immunodeficiency secondary to organ transplantation --- r_associated #0: 31 --> en:immunodeficiency secondary to neoplasm
    n1=en:immunodeficiency secondary to organ transplantation | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=31
  18. en:age-related immunodeficiency --- r_associated #0: 30 --> en:immunodeficiency secondary to neoplasm
    n1=en:age-related immunodeficiency | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=30
  19. en:immune system finding --- r_associated #0: 30 --> en:immunodeficiency secondary to neoplasm
    n1=en:immune system finding | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=30
  20. présentation sacro-iliaque droite antérieure --- r_associated #0: 30 --> en:immunodeficiency secondary to neoplasm
    n1=présentation sacro-iliaque droite antérieure | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=30
  21. en:immunodeficiency secondary to corticosteroid --- r_associated #0: 29 --> en:immunodeficiency secondary to neoplasm
    n1=en:immunodeficiency secondary to corticosteroid | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=29
  22. déficit immunitaire secondaire à un cancer --- r_associated #0: 28 --> en:immunodeficiency secondary to neoplasm
    n1=déficit immunitaire secondaire à un cancer | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=28
  23. immunodéficience secondaire à un néoplasme --- r_associated #0: 27 --> en:immunodeficiency secondary to neoplasm
    n1=immunodéficience secondaire à un néoplasme | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=27
  24. en:immunodeficiency following hereditary defective response to epstein-barr virus --- r_associated #0: 26 --> en:immunodeficiency secondary to neoplasm
    n1=en:immunodeficiency following hereditary defective response to epstein-barr virus | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=26
  25. en:neoplastic syndrome --- r_associated #0: 26 --> en:immunodeficiency secondary to neoplasm
    n1=en:neoplastic syndrome | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=26
  26. en:aids --- r_associated #0: 24 --> en:immunodeficiency secondary to neoplasm
    n1=en:aids | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=24
  27. en:anti-AIDS --- r_associated #0: 23 --> en:immunodeficiency secondary to neoplasm
    n1=en:anti-AIDS | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=23
  28. S.I.D.A --- r_associated #0: 21 --> en:immunodeficiency secondary to neoplasm
    n1=S.I.D.A | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=21
  29. en:common variable immunodeficiency --- r_associated #0: 20 --> en:immunodeficiency secondary to neoplasm
    n1=en:common variable immunodeficiency | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=20
  30. en:immunodeficiency secondary to chemotherapy --- r_associated #0: 20 --> en:immunodeficiency secondary to neoplasm
    n1=en:immunodeficiency secondary to chemotherapy | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=20
  31. en:immunodeficiency secondary to chemotherapy (excluding corticosteroids) --- r_associated #0: 20 --> en:immunodeficiency secondary to neoplasm
    n1=en:immunodeficiency secondary to chemotherapy (excluding corticosteroids) | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=20
  32. en:immunodeficiency secondary to oncology chemotherapy --- r_associated #0: 20 --> en:immunodeficiency secondary to neoplasm
    n1=en:immunodeficiency secondary to oncology chemotherapy | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=20
  33. en:immunodeficiency secondary to radiation therapy --- r_associated #0: 20 --> en:immunodeficiency secondary to neoplasm
    n1=en:immunodeficiency secondary to radiation therapy | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=20
  34. en:immunodeficiency secondary to transplantation chemotherapy --- r_associated #0: 20 --> en:immunodeficiency secondary to neoplasm
    n1=en:immunodeficiency secondary to transplantation chemotherapy | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=20
  35. en:secondary immune deficiency disorder --- r_associated #0: 20 --> en:immunodeficiency secondary to neoplasm
    n1=en:secondary immune deficiency disorder | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=20
  36. néoplasme --- r_associated #0: 20 --> en:immunodeficiency secondary to neoplasm
    n1=néoplasme | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=20
  37. Syndrome d'immunodéficience acquise --- r_associated #0: 15 --> en:immunodeficiency secondary to neoplasm
    n1=Syndrome d'immunodéficience acquise | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=15
  38. allocations --- r_associated #0: 10 --> en:immunodeficiency secondary to neoplasm
    n1=allocations | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=10
  39. en:acquired immune deficiency syndrome --- r_associated #0: 10 --> en:immunodeficiency secondary to neoplasm
    n1=en:acquired immune deficiency syndrome | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=10
  40. en:right sacrum anterior position --- r_associated #0: 10 --> en:immunodeficiency secondary to neoplasm
    n1=en:right sacrum anterior position | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=10
  41. Syndrome d'Immunodéficience Acquise --- r_associated #0: 5 --> en:immunodeficiency secondary to neoplasm
    n1=Syndrome d'Immunodéficience Acquise | n2=en:immunodeficiency secondary to neoplasm | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr